Zaki, Amr M.
Pasadhika, Sirichai
Huang, Jerry C.
Thomas, Akshay S.
Burkholder, Bryn M.
Lim, Lyndell L. http://orcid.org/0000-0003-2491-685X
Llop, Stephanie M.
Suhler, Eric B.
Adamus, Grazyna
Rosenbaum, James T.
Funding for this research was provided by:
Rheumatology Research Foundation
Gift fund from family in Portland, OR, USA
Article History
Received: 1 April 2023
Revised: 30 July 2023
Accepted: 10 August 2023
First Online: 19 August 2023
Competing interests
: AST: consultant for Alimera, Allergan, Avesis, Bausch & Lomb, Eyepoint, Genentech, Zeiss. SML: Eyepoint Pharmaceuticals. JTR: consultant for Abbvie, Gilead, Roche, Horizon, Eyevensys, Santen, UCB, Corvus, and Affibody; royalties from UpToDate; clinical trial support from Pfizer and Horizon; and data monitoring for BMS-Celgene and Lilly. The remaining authors declare no competing interests.